This inventor holds 8 USPTO granted patents, plus 13 CIPO patents and 3 EPO patents. Top assignees: Replicor Inc, Other. Active years: 2013-2017.
Location History:
- Mount-Royal, CA (2013)
- Montréal, CA (2014)
- Montreal, CA (2015 - 2017)
Company Filing History:
6 out of 11 
2 out of 834,411 Years Active: 2013-2017
Title: The Innovative Contributions of Michel Bazinet
Introduction
Michel Bazinet is a prominent inventor based in Montreal, Canada. He has made significant contributions to the field of pharmaceuticals, particularly in the development of treatments for various viral infections and diseases. With a total of eight patents to his name, Bazinet's work has the potential to impact many lives.
Latest Patents
Among his latest patents, Bazinet has developed methods involving oligonucleotide chelate complexes. These pharmaceutical compositions are designed for the treatment of viral infections, hypercholesterolemia, hypertriglyceridemia, Alzheimer's disease, prion disease, and Duchenne's muscular dystrophy. Another notable patent focuses on methods for treating hepatitis B and hepatitis D infections. This method involves administering a first pharmaceutically acceptable agent that removes the hepatitis B surface antigen from the blood, along with a second agent that stimulates immune function.
Career Highlights
Throughout his career, Michel Bazinet has worked with various companies, including Replicor Inc. His innovative approaches and dedication to research have established him as a key figure in the pharmaceutical industry.
Collaborations
One of his notable collaborators is Andrew Vaillant. Their partnership has contributed to the advancement of research and development in their field.
Conclusion
Michel Bazinet's contributions to pharmaceutical innovations demonstrate his commitment to improving health outcomes through scientific research. His patents reflect a deep understanding of complex medical challenges and a drive to find effective solutions.